These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 4075371)

  • 21. The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies.
    Windh RT; Little PJ; Kuhn CM
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1361-74. PubMed ID: 7791109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is withdrawal hyperalgesia in morphine-dependent mice a direct effect of a low concentration of the residual drug?
    Rubovitch V; Pick CG; Sarne Y
    Addict Biol; 2009 Sep; 14(4):438-46. PubMed ID: 19489750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in brain cyclic AMP metabolism and acetylcholine and dopamine during narcotic dependence and withdrawal.
    Merali Z; Singhal RL; Hrdina PD; Ling GM
    Life Sci; 1975 Jun; 16(12):1889-94. PubMed ID: 168451
    [No Abstract]   [Full Text] [Related]  

  • 24. Involvement of cyclic AMP systems in morphine physical dependence in mice: prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor.
    Mamiya T; Noda Y; Ren X; Hamdy M; Furukawa S; Kameyama T; Yamada K; Nabeshima T
    Br J Pharmacol; 2001 Mar; 132(5):1111-7. PubMed ID: 11226142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain acetylcholine and choline following acute and chronic morphine treatment and during withdrawal.
    Bhargava HN; Way EL
    J Pharmacol Exp Ther; 1975 Jul; 194(1):65-73. PubMed ID: 1171222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopaminergic influence on withdrawal jumping behavior in morphine-dependent mice.
    Tseng LF; Brase DA; Loh HH
    Res Commun Chem Pathol Pharmacol; 1976 Nov; 15(3):435-46. PubMed ID: 1033590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of src-kinase attenuates naloxone-precipitated opioid withdrawal syndrome in mice.
    Rehni AK; Singh N
    Behav Pharmacol; 2011 Apr; 22(2):182-90. PubMed ID: 21285874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of supraspinal and peripheral naloxonazine-insensitive opioid receptor sites in the expression of μ-opioid receptor agonist-induced physical dependence.
    Mori T; Komiya S; Uzawa N; Inoue K; Itoh T; Aoki S; Shibasaki M; Suzuki T
    Eur J Pharmacol; 2013 Sep; 715(1-3):238-45. PubMed ID: 23707904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence against a role of brain 5-hydroxytryptamine in the development of physical dependence upon morphine in mice.
    Marshall I; Grahame-Smith DG
    J Pharmacol Exp Ther; 1971 Dec; 179(3):634-41. PubMed ID: 4257807
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition by naloxone of tolerance and dependence in mice treated acutely and chronically with morphine.
    Yano I; Takemori AE
    Res Commun Chem Pathol Pharmacol; 1977 Apr; 16(4):721-34. PubMed ID: 16322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase.
    Ren X; Noda Y; Mamiya T; Nagai T; Nabeshima T
    Behav Brain Res; 2004 Jul; 152(2):243-50. PubMed ID: 15196791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphine dependence and diabetes. I. The development of morphine dependence in streptozotocin-diabetic rats and spontaneously diabetic C57BL/KsJ mice.
    Shook JE; Dewey WL
    J Pharmacol Exp Ther; 1986 Jun; 237(3):841-7. PubMed ID: 3712281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased elevated plus maze open-arm time in mice during naloxone-precipitated morphine withdrawal.
    Hodgson SR; Hofford RS; Norris CJ; Eitan S
    Behav Pharmacol; 2008 Dec; 19(8):805-11. PubMed ID: 19020415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative study of the physical dependence on proline analog of dermorphin and morphine].
    Guzevatykh LS; Valuĭskikh DV; Voronina TA; Emel'ianova TG; Andreeva LA; Alfeeva LIu; Miasoedov NF
    Eksp Klin Farmakol; 2005; 68(3):16-9. PubMed ID: 16047673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice.
    Nemoto W; Sato T; Nakagawasai O; Yaoita F; Silberring J; Tadano T; Tan-No K
    Neuropeptides; 2013 Jun; 47(3):187-91. PubMed ID: 23290539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of L-745,870, a dopamine D4 receptor antagonist, on naloxone-induced morphine dependence in mice.
    Mamiya T; Matsumura T; Ukai M
    Ann N Y Acad Sci; 2004 Oct; 1025():424-9. PubMed ID: 15542745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitation of physical dependence in mice by naloxone-precipitated jumping after a single dose of morphine.
    Smits SE
    Res Commun Chem Pathol Pharmacol; 1975 Apr; 10(4):651-61. PubMed ID: 1171511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of ibogaine on naloxone-precipitated withdrawal syndrome in chronic morphine-dependent rats.
    Dzoljic ED; Kaplan CD; Dzoljic MR
    Arch Int Pharmacodyn Ther; 1988; 294():64-70. PubMed ID: 3233054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential involvement of tyrosine phosphatase and calpain-related pathways in opioid withdrawal syndrome in mice.
    Rehni AK; Singh N
    Behav Pharmacol; 2012 Jun; 23(3):302-9. PubMed ID: 22495184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenothiazine-type antipsychotics may attenuate naloxone-precipitated withdrawal jumping in morphine-dependent mice.
    Wu SZ; Chen KT; Chen JY; Sung KC; Wang JJ; Liu KS; Chu CC
    Acta Anaesthesiol Taiwan; 2012 Dec; 50(4):167-71. PubMed ID: 23385039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.